Tag
biogen
-
Adieu, Aduhelm: Biogen pulls plug on controversial Alzheimer’s drug
The discontinuation of Biogen’s Aduhelm is a cautionary tale of overpromising, under-delivering, and an inside look at FDA sausage-making.
-
Disease-awareness campaigns merit extra scrutiny, experts say
This is part 2 of a package on sponsored disease awareness campaigns and other controversial drug marketing practices, focusing on…
-
Explaining Biogen’s controversial ‘MCI’ advertising to your audience
New marketing campaigns about forgetfulness and distraction could lead people to seek the costly Aduhelm drug for Alzheimer’s disease even…